Amazon to create 5,000 full-time jobs
AMAZON is boosting staff in 17 US warehouses, adding more than 5,000 full-time jobs to meet brisk demand for products sold by the world's biggest web retailer. Amazon is also hiring 2,000 customer-service staff.
The retailer plans to open five more facilities this year, after adding 20 last year.
CIRCLE IN &EURO;2.3M DEAL FOR TUNISIA LICENCE
CIRCLE Oil has paid €2.3m for the remaining 30pc of an exploration licence on a site off the coast of Tunisia. The Limerick-headquartered oil and gas company estimates that two prospects at the location contain as much as 180m barrels of oil.
"The increased interest provides us with greater flexibility for progressing this permit, and maximising value in the event of a successful well," said chief executive Chris Green.
FAST-FOOD WORKERS IN PAY WALKOUT
THOUSANDS of fast-food workers across North America will walk off the job today, calling for $15-an-hour pay (€11.32). Employees of eateries like McDonald's and Wendy's will strike in New York City, Chicago and other cities.
Congress last voted to raise the US federal minimum wage in 2007 and President Barack Obama's recent call to raise it to $9 an hour from $7.25 was unpopular with lawmakers.
BANK DENIED TIME TO BOOST CAPITAL
BARCLAYS, Britain's second-largest bank by assets, won't get the extra time it was seeking to meet regulators' demands to boost capital. The Prudential Regulation Authority has told the lender it won't get until the end of 2014 to increase capital to at least 3pc of assets.
To meet the ratio this year, the bank will have to either raise £7bn (€8.1bn) in equity or cut £240bn of assets.
ABBVIE FORECAST UP AFTER SALES BOOST
DRUG manufacturer AbbVie, which employs 400 people in Sligo, Cork and Dublin, has raised its 2014 forecast after sales of its top medicine Humira jumped between April and June.
Full-year profits are now expected to hit about $3.07 to $3.13 a share, according to the Illinois-headquartered company. Its previous outlook indicated $3.03 a share. Total sales grew 4.4pc in the three months ending in June, to $4.69bn, while Humira sales alone increased 12pc. The rheumatoid arthritis drug is the backbone of the company.